Suppr超能文献

棉鼠中 RSV 母源免疫的相关结局。

Correlative outcomes of maternal immunization against RSV in cotton rats.

机构信息

Research Department, Sigmovir Biosystems Inc. Rockville, Rockville, MD, USA.

Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, USA.

出版信息

Hum Vaccin Immunother. 2022 Dec 30;18(7):2148499. doi: 10.1080/21645515.2022.2148499. Epub 2022 Dec 12.

Abstract

Maternal anti-respiratory syncytial virus (RSV) antibodies protect neonates from RSV disease throughout first weeks of life. Previous studies of maternal immunization in cotton rats showed that a single immunization during pregnancy of RSV-primed dams with virus-like particles (VLPs) assembled with pre-fusion F protein and the wild type G protein boosted their RSV serum antibody concentration and protected pups early in life against RSV challenge. We extended these findings by evaluating responses to RSV infection in litters from two consecutive pregnancies of immunized dams. Using an RSV-primed population of VLP-vaccinated and unvaccinated dams, we defined correlations between dams' and litters' RSV neutralizing antibodies (NA); between litters' NA and protection; and between litter's NA and their lung expression of selected cytokines, of a first or of a second pregnancy. Lung pathology was also evaluated. We found positive correlation between the NA titers in the dams at delivery and the NA in their first and second litters and negative correlations between the litters' NA and protection from RSV challenge. Vaccination of dams modulated the mRNA expression for IFNγ and IL-6 and lung pathology in the first and in the second litter at different times after birth, even in the absence of detectable NA. Maternal RSV vaccination enhanced the levels of antibodies transferred to offspring and their protection from challenge. Importantly, maternal vaccination also impacted the immunological and inflammatory response of the offspring's lungs well into maturity, and after the antiviral effect of maternally transferred NA waned or was no longer detectable.

摘要

母体抗呼吸道合胞病毒 (RSV) 抗体可在新生儿生命的头几周内保护其免受 RSV 疾病的侵害。先前在棉鼠中进行的母体免疫研究表明,在 RSV 致敏的孕鼠中进行单次免疫接种,用预融合 F 蛋白和野生型 G 蛋白组装的病毒样颗粒 (VLPs) 可提高其 RSV 血清抗体浓度,并在生命早期保护幼鼠免受 RSV 挑战。我们通过评估免疫接种孕鼠连续两次妊娠所生幼鼠对 RSV 感染的反应,扩展了这些发现。使用 RSV 致敏的 VLP 疫苗接种和未接种的孕鼠群体,我们定义了母体和幼鼠 RSV 中和抗体 (NA) 之间的相关性;幼鼠的 NA 与保护之间的相关性;以及幼鼠的 NA 与其肺中选定细胞因子的表达(第一或第二妊娠)之间的相关性。还评估了肺病理学。我们发现,分娩时母体的 NA 滴度与第一和第二胎的 NA 之间呈正相关,而幼鼠的 NA 与 RSV 挑战的保护之间呈负相关。母体疫苗接种可调节第一和第二胎出生后不同时间的 IFNγ 和 IL-6 的 mRNA 表达和肺病理学,即使不存在可检测到的 NA 也是如此。母体 RSV 疫苗接种增强了转移到后代的抗体水平及其免受挑战的保护。重要的是,母体疫苗接种还会影响后代肺部的免疫和炎症反应,直到成熟,并且在母体转移的 NA 的抗病毒作用减弱或不再可检测到时也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c78d/9766472/debb32f5fc02/KHVI_A_2148499_F0001_OC.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验